Log In
BCIQ
Print this Print this
 

Surfaxin LS

  Manage Alerts
Collapse Summary General Information
Company Windtree Therapeutics Inc.
DescriptionNext-generation, lyophilized surfaxin formulation
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationRespiratory distress syndrome (RDS)
Indication DetailsTreat neonatal respiratory distress syndrome (RDS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today